NEWS

CEO of COVID vaccine company Pfizer admits on CNN that he hasn’t received jab

Updated: December 17, 2020 at 12:57 pm EST  See Comments

December 17, 2020 (LifeSiteNews) – Amid ongoing serious safety concerns regarding Pfizer’s new COVID-19 vaccine, and its lack of any real necessity, the pharmaceutical giant’s CEO Albert Bourla said Monday that he hasn’t received the vaccine yet because he doesn’t want to be perceived as cutting in line.

“I haven’t taken it yet and we are having an ethical committee dealing with the question of who is getting it,” Bourla told CNN.

According to the New York Post, Bourla explained that the Centers for Disease Control (CDC) had prioritized front-line health workers along with nursing home residents and staff.

“Given that there are very strict allocation rules that the CDC has voted [on], we are very sensitive not to cut the queue and get vaccinated before,” he said.

However, he did indicate that he was open to receiving the shots in the future in order to boost confidence for the product among the public.

“People will believe much more [in the safety of the vaccine] if the CEO gets vaccinated,” Bourla said.

Such gestures of confidence may become ever more necessary as recent studies have found such belief and trust in vaccines in general has been rapidly declining in recent months.

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors

Advertisement
Atlin Tumbler Double Wall Stainless Steel Vacuum Insulation Travel Mug, Coffee Cup
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
A Quick Note…

Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Official Street Preachers and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.